A Cross-Sectional Study to Evaluate Antimicrobial Susceptibility of Uropathogens from South Punjab, Pakistan

References

• Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269–284. doi:10.1038/nrmicro3432
   PubMed Web of Science ®Google Scholar
• McLellan LK, Hunstad DA. Urinary tract infection: pathogenesis and outlook. Trends Mol Med. 2016;22(11):946–957. doi:10.1016/j.molmed.2016.09.003
   PubMed Web of Science ®Google Scholar
• Heffner VA, Gorelick MH. Pediatric urinary tract infection. Clin Pediatr Emerg Med. 2008;9(4):233–237. doi:10.1016/j.cpem.2008.09.009
   Google Scholar
• Schaeffer A, Rajan N, Cao Q, et al. Host pathogenesis in urinary tract infections. Int J Antimicrob Agents. 2001;17(4):245–251. doi:10.1016/S0924-8579(01)00302-8
   Web of Science ®Google Scholar
• Behzadi P, Behzadi E. The microbial agents of urinary tract infections at central laboratory of Dr. Shariati Hospital, Tehran, Iran. Turk Klin Tip Bilim. 2008;28(4):445.
   Google Scholar
• Stamm WE. Urinary tract infections and pyelonephritis. In: Harrison's Principles of Internal Medicine. Vol. 16, 2005:1715.
   Google Scholar
• Haque R, Akter ML, Salam MA. Prevalence and susceptibility of uropathogens: a recent report from a teaching hospital in Bangladesh. BMC Res Notes. 2015;8(1):1–5. doi:10.1186/s13104-015-1408-1
   Google Scholar
• Idrees MM, Saeed A. Genetic and molecular mechanisms of multidrug-resistance in uropathogens and novel therapeutic combat. In: Biochemistry of Drug Resistance. Springer; 2021:505–538.
   Google Scholar
• Rampure R, Gangane R, Oli AK, Chandrakanth K. Prevalence of MDR-ESBL producing Klebsiella pneumoniae isolated from clinical samples. J Microbiol Biotech Res. 2013;3(1):32–39.
   Google Scholar
• Issakhanian L, Behzadi P. Antimicrobial agents and urinary tract infections. Curr Pharm Des. 2019;25(12):1409–1423. doi:10.2174/1381612825999190619130216
   PubMed Web of Science ®Google Scholar
• Ahmed S, Rashid H. Urinary tract infection in adults. Bangladesh Renal J. 1996;15:23–31.
   Google Scholar
• Gold HS, Moellering RC Jr. Antimicrobial-drug resistance. N Engl J Med. 1996;335(19):1445–1453. doi:10.1056/NEJM199611073351907
   PubMed Web of Science ®Google Scholar
• Khanum H, Munir F, Shafiullah A, Muznebin F. Prevalence and comparative likelihood of urinary tract infection (UTI) among female out patients in BSMMU. Bangladesh J Zool. 2012;40(2):231–239. doi:10.3329/bjz.v40i2.14317
   Google Scholar
• Sarshar M, Behzadi P, Ambrosi C, Zagaglia C, Palamara AT, Scribano D. FimH and anti-adhesive therapeutics: a disarming strategy against uropathogens. Antibiotics. 2020;9(7):397. doi:10.3390/antibiotics9070397
   Web of Science ®Google Scholar
• Behzadi P. Classical chaperone-usher (CU) adhesive fimbriome: uropathogenic Escherichia coli (UPEC) and urinary tract infections (UTIs). Folia Microbiol (Praha). 2020;65(1):45–65. doi:10.1007/s12223-019-00719-x
   PubMed Web of Science ®Google Scholar
• Khonsari MS, Behzadi P, Foroohi F. The prevalence of type 3 fimbriae in Uropathogenic Escherichia coli isolated from clinical urine samples. Meta Gene. 2021;28:100881. doi:10.1016/j.mgene.2021.100881
   Web of Science ®Google Scholar
• Septiana L, Harahap U, Ginting F. Identification of gyrA gene resistance on bacteria Escherichia coli and Klebsiella pneumoniae in urinary tract infection patients in Haji Adam Malik Center Hospital, Medan, Indonesia. Asian J Pharm Res. 2020;8(4):27–29.
   Google Scholar
• Hozzari A, Behzadi P, Kerishchi Khiabani P, Sholeh M, Sabokroo N. Clinical cases, drug resistance, and virulence genes profiling in Uropathogenic Escherichia coli. J Appl Genet. 2020;61(2):265–273. doi:10.1007/s13353-020-00542-y
   PubMed Web of Science ®Google Scholar
• Ahmadi M, Ranjbar R, Behzadi P, Mohammadian T. Virulence factors, antibiotic resistance patterns, and molecular types of clinical isolates of Klebsiella Pneumoniae. Expert Rev Anti Infect Ther. 2021:1–10. doi:10.1080/14787210.2022.1990040
   Web of Science ®Google Scholar
• Behzadi P, García-Perdomo HA, Karpiński TM, Issakhanian L. Metallo-ß-lactamases: a review. Mol Biol Rep. 2020;47(8):6281–6294. doi:10.1007/s11033-020-05651-9
   PubMed Web of Science ®Google Scholar
• Behzadi P, Urbán E, Matuz M, Benkő R, Gajdács M. The role of gram-negative bacteria in urinary tract infections: current concepts and therapeutic options. Adv Microbiol Infect Dis Public Health. 2020:35–69. doi:10.1007/5584_2020_566
   Google Scholar
• Farrell D, Morrissey I, De Rubeis D, Robbins M, Felmingham D. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect. 2003;46(2):94–100. doi:10.1053/jinf.2002.1091
   PubMed Web of Science ®Google Scholar
• Behzadi P, Behzadi E. Uropathogenic Escherichia coli: an ideal resource for DNA microarray probe designing. Paper presented at: International Conference on Bioinformatics and Biomedical Engineering;2017.
   Google Scholar
• Malik J, Javed N, Malik F, Ishaq U, Ahmed Z. Microbial Resistance in Urinary Tract Infections. Cureus. 2020;12(5). doi:10.7759/cureus.8110
   Web of Science ®Google Scholar
• Sohail M, Khurshid M, Saleem HGM, Javed H, Khan AA. Characteristics and antibiotic resistance of urinary tract pathogens isolated from Punjab, Pakistan. Jundishapur J Microbiol. 2015;8(7). doi:10.5812/jjm.19272v2
   Web of Science ®Google Scholar
• Stamm WE. Measurement of pyuria and its relation to bacteriuria. Am J Med. 1983;75(1):53–58. doi:10.1016/0002-9343(83)90073-6
   Web of Science ®Google Scholar
• Lum K, Meers P. Boric acid converts urine into an effective bacteriostatic transport medium. J Infect. 1989;18(1):51–58. doi:10.1016/S0163-4453(89)93667-0
   Web of Science ®Google Scholar
• Phuong NT, Lee BJ, Choi JK, Kang JS, Kwon KI. Enantioselective pharmacokinetics of carvedilol in human volunteers. Arch Pharm Res. 2004;27(9):973–977. doi:10.1007/BF02975853
   Web of Science ®Google Scholar
• Cheesbrough M. District Laboratory Practice in Tropical Countries, Part 2. Cambridge university press; 2005.
   Google Scholar
• Ali Raza J, Movahed A. Use of cardiovascular medications in the elderly. Int J Cardiol. 2002;85(2–3):203–215. doi:10.1016/S0167-5273(02)00193-6
   Web of Science ®Google Scholar
• Johnson TN. The problems in scaling adult drug doses to children. Arch Dis Child. 2008;93(3):207–211. doi:10.1136/adc.2006.114835
   PubMed Web of Science ®Google Scholar
• Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of Clinical Microbiology. 12th ed. American Society of Microbiology; 2019.
   Google Scholar
• Sahil A. Manual of Laboratory Medicine. 3rd ed. Armed Forces Institute of Pathology; 1970:Rawalpindi–Pakistan.
   Google Scholar
• Humphries R, Bobenchik AM, Hindler JA, Schuetz AN. Overview of changes to the clinical and laboratory standards institute performance standards for antimicrobial susceptibility testing, M100. J Clin Microbiol. 2021;59(12):e00213–00221. doi:10.1128/JCM.00213-21
   PubMed Web of Science ®Google Scholar
• Testing ECoAS. EUCAST: clinical breakpoints and dosing of antibiotics; 2019.
   Google Scholar
• Weinstein MP, Lewis JS. The clinical and laboratory standards institute subcommittee on antimicrobial susceptibility testing: background, organization, functions, and processes. J Clin Microbiol. 2020;58(3):e01864–01819. doi:10.1128/JCM.01864-19
   PubMed Web of Science ®Google Scholar
• Palewar M, Mudshingkar S, Dohe V, Bharadwaj R. Spectrum and antimicrobial susceptibility pattern of uropathogens: indoor versus outdoor isolates. Int J Trop Dis Health. 2017;27(1):1–7. doi:10.9734/IJTDH/2017/36611
   Google Scholar
• Akhtar SMH, Sattar A, Rizwan W, Cheema NA, Anwar A. Microbes and antibiotic susceptibility patterns of urinary tract infections in toilet-trained children at a Tertiary Care Hospital of Sialkot, Pakistan. Prof Med J. 2021;28(01):22–26. doi:10.29309/TPMJ/2021.28.01.4657
   Google Scholar
• Muhammad A, Khan S, Ali N, Rehman M, Ali I. Prevalence and antibiotic susceptibility pattern of uropathogens in outpatients at a tertiary care hospital. New Microbes New Infect. 2020;36:100716. doi:10.1016/j.nmni.2020.100716
   PubMed Web of Science ®Google Scholar
• Mohammed MA, Alnour TM, Shakurfo OM, Aburass MM. Prevalence and antimicrobial resistance pattern of bacterial strains isolated from patients with urinary tract infection in Messalata Central Hospital, Libya. Asian Pac J Trop Med. 2016;9(8):771–776. doi:10.1016/j.apjtm.2016.06.011
   PubMed Web of Science ®Google Scholar
• Falagas ME, Maraki S, Karageorgopoulos DE, Kastoris AC, Mavromanolakis E, Samonis G. Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin. Int J Antimicrob Agents. 2010;35(3):240–243. doi:10.1016/j.ijantimicag.2009.10.019
   PubMed Web of Science ®Google Scholar
• Woldemariam HK, Geleta DA, Tulu KD, et al. Common uropathogens and their antibiotic susceptibility pattern among diabetic patients. BMC Infect Dis. 2019;19(1):1–10.
   Web of Science ®Google Scholar
• Mehrishi P, Faujdar SS, Kumar S, Solanki S, Sharma A. Antibiotic susceptibility profile of uropathogens in rural population of Himachal Pradesh, India: where We are heading? Biomed Biotech Res J. 2019;3(3):171.
   Google Scholar
• Jena J, Sahoo RK, Debata NK, Subudhi E. Prevalence of TEM, SHV, and CTX-M genes of extended-spectrum β-lactamase-producing Escherichia coli strains isolated from urinary tract infections in adults. 3 Biotech. 2017;7(4):1–7. doi:10.1007/s13205-017-0879-2
   Google Scholar
• Lim K-T, Yasin R, Yeo -C-C, Puthucheary S, Thong K-L. Characterization of multidrug resistant ESBL-producing Escherichia coli isolates from hospitals in Malaysia. J Biomed Biotechnol. 2009;2009:1–10. doi:10.1155/2009/165637
   Google Scholar
• Xue Y, Chen J, Hua Y. Resistance of strains producing extended-spectrum [beta]-lactamases and genotype distribution among Escherichia coli in China. Pak J Zool. 2012;44(2):53–57.
   Web of Science ®Google Scholar
• Pouladfar G, Basiratnia M, Anvarinejad M, Abbasi P, Amirmoezi F, Zare S. The antibiotic susceptibility patterns of uropathogens among children with urinary tract infection in Shiraz. Medicine. 2017;96(37):e7834. doi:10.1097/MD.0000000000007834
   Web of Science ®Google Scholar
• Lu P-L, Liu Y-C, Toh H-S, et al. Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009–2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Int J Antimicrob Agents. 2012;40:S37–S43. doi:10.1016/S0924-8579(12)70008-0
   PubMed Web of Science ®Google Scholar
• Falup-Pecurariu O, Leibovitz E, Bucur M, Lixandru R, Bleotu L, Falup-Pecurariu C. High resistance rates to 2 nd and 3 rd generation cephalosporins, ciprofloxacin and gentamicin of the uropathogens isolated in young infants hospitalized with first urinary tract infection. Biomed Res. 2017;28(20):8675–8680.
   Google Scholar
• Prasad B, Arora P. Antibiotic susceptibility profiling of bacterial biodiversity associated with urinary tract infections. World Sci News. 2021;155:129–139.
   Google Scholar
• Sharifian M, Karimi A, Tabatabaei SR, Anvaripour N. Microbial sensitivity pattern in urinary tract infections in children: a single center experience of 1177 urine cultures. Jpn J Infect Dis. 2006;59(6):380.
   PubMed Web of Science ®Google Scholar
• Sharmin S, Alamgir F, Fahmida M, Saleh AA. Antimicrobial sensitivity pattern of uropathogens in children. Bangladesh J Med Microbiol. 2009;3(2):18–22. doi:10.3329/bjmm.v3i2.5322
   Google Scholar